Gynae BT 2017
Ongoing studies
POST-OP HIGH RISK CERVICAL CANCERS: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic RT With or Without Adjuvant (Pacli + Carbo every 21 days x 4 cycles) Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy
RTOG-0724 Lead Group: RTOG
SWOG NSABP NCIC NCCTG GOG ECOG CALGB ACOSOG SWOG RTOG NSABP NCIC NCCTG ECOG CALGB ACOSOG
To Date: 163 Target: 400 (09/15/14)
POST-OP INTERMEDIATE RISK CERVICAL CANCERS: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemo- radiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic LND dissection
GOG-0263 Lead Group: GOG
Target: 534
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
Made with FlippingBook - Online catalogs